Ramon has a distinguished track record in entrepreneurship, innovation, and executive management in the digital health and life sciences industries. Most recently, Ramon held the role of Chief Technology Officer and Vice President, Strategy for QIAGEN N.V., a global provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.
While at QIAGEN, Ramon founded QIAGEN Digital Insights (QDI) to build on its acquisition of Ingenuity Systems for entry into the AI, data science, and informatics markets. Ramon led the effort to found a new business unit, reporting to the CEO, to spearhead and accelerate this market entry, and helped recruit the founding QDI leadership team. He subsequently defined and drove the market entry roadmap and technology and data strategy that ultimately delivered a portfolio of 30 data science products and services through internal R&D and external acquisitions. Ramon further led the development and commercialization of an award-winning AI-based precision medicine product line that successfully guided care of 1M+ patients, unlocked a data rights strategy that enabled QDI to expand into the real-world evidence market. QDI rapidly establishing QIAGEN as an acclaimed market leader in research and clinical informatics markets, and achieved investor recognition as one of QIAGEN’s “crown jewels” (JP Morgan, 2019).
Prior to QIAGEN, Ramon founded Ingenuity Systems out of Stanford University to use AI and data curation to unlock the value of the human genome. As founding CTO and SVP Research, Ramon drove the venture-funded development of an award-winning core technology platform, unique data assets, and growing product lines (including IPA - Ingenuity Pathway Analysis) that ultimately defined a new market segment around genome interpretation and systems biology. Through these efforts, Ingenuity established itself as a global leader in AI-driven genome interpretation, predictive drug discovery, and cloud-based data management for pharma, biotech, and life sciences enterprises. QIAGEN acquired Ingenuity in 2013 for $105M to serve as a cornerstone for its expansion into sequencing and software and data markets.
Prior to Ingenuity, Ramon held several technology leadership positions at Stanford Medicine, where he founded SUMMIT, the Stanford University Medical Media and Information Technologies lab, an innovation lab for digital approaches to medical education and clinical decision making. Ramon also serves as principal at Digital Alchemy, a consultancy specializing in innovation, product, business model and go-to-market strategies for digital health startups as well as digital transformation and tech+data strategy creation for life sciences, pharma/biotech, and diagnostics organizations.
Ramon received his Ph.D. and M.S. in Biomedical Data Sciences from Stanford Medical School, his B.S. in Computer Science from Stanford University, and a B.A. in English and French Literature from Stanford University. He holds dual citizenship (Swiss and American), speaks 4 languages, has authored numerous patents and publications, and advises and presents on digital health topics around the world.